New sub-projects in Research Area C

23/09/2021 | News

SFB1399 grows and two new sub-projects have been included.

C07 and C08 are the new additions to the SFB1399 with immediate effect. Accordingly, two new Principle Investigators Dr. Filippo Beleggia and Dr. Johannes Brägelmann have joined.

  • Project C07
  • Project C08
Back
SFB 1399 Mechanisms of Drug Sensitivity and Resistance in Small Cell Lung Cancer

SFB 1399 Mechanisms of Drug Sensitivity
and Resistance in Small Cell Lung Cancer

c/o Department of Translational Genomics
University of Cologne
Weyertal 115b
50931 Cologne, Germany

+49-221-478-98777
info[@]sfb1399.de

Imprint
Privacy Policy

Partners:

University of Cologne University Hospital of Cologne University Hospital Essen Max Planck Institute for Metabolism Research TRON – Translational Oncology at the University Medical Center of the Johannes Gutenberg University Main University of Bonn University of Frankfurt Deutsche Forschungsgemeinschaft CIO Centrum für integrierte Onkologie Aachen Köln Bonn Düsseldorf Lung Cancer Group Cologne